Viswanadhan Krishnan 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Transactions
- Award
Restricted stock units
2025-03-05+24,300→ 24,300 total→ Common stock (24,300 underlying) - Award
Stock options (right to buy)
2025-03-05+55,374→ 55,374 totalExercise: $33.95Exp: 2035-03-05→ Common stock (55,374 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]This option was granted on March 5, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.